CAPTRUST Financial Advisors
ONC

CAPTRUST Financial Advisors’s BeOne Medicines Ltd ONC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,617
Closed -$480K – 3420
2026
Q1 		$480K Buy
+1,617
New +$523K ﹤0.01% 2054
2022
Q3 		– Sell
-17
Closed -$3K – 4169
2022
Q2 		$3K Sell
17
-6
-26% -$937 ﹤0.01% 4360
2022
Q1 		$4K Sell
23
-6
-21% -$1.28K ﹤0.01% 4289
2021
Q4 		$8K Hold
29
– – ﹤0.01% 3861
2021
Q3 		$11K Buy
29
+20
+222% +$6.54K ﹤0.01% 3571
2021
Q2 		$3K Hold
9
– – ﹤0.01% 4070
2021
Q1 		$3K Buy
+9
New +$2.98K ﹤0.01% 3952

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CAPTRUST Financial Advisors's ONC Position: Q2 2026 in Review

CAPTRUST Financial Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 1,617 shares — an estimated $480K sold.

CAPTRUST Financial Advisors first reported a position in ONC in Q1 2021 and held it in 7 quarters. The position peaked at $480K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • CAPTRUST Financial Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,617 BeOne Medicines Ltd shares in Q2 2026, an estimated $480K.
  • CAPTRUST Financial Advisors first reported a position in BeOne Medicines Ltd in Q1 2021 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's BeOne Medicines Ltd position peaked at $480K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.